Aryan Sharma

Aryan Sharma

Auto-generated profile, based on publicly available information

Aryan Sharma

University of Nottingham Medical School , Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Derby Road, Nottingham NG7 2UH , Nottinghamshire

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2025 in Wellcome Open Research
Verified
Journal Article
Open access
DMDaniel M Maloney
Daniel M Maloney
GFGoncalo Fernandes
Goncalo Fernandes
SJSeema Jasim
Seema Jasim
TWTom Williams
Tom Williams
SNSarah Namugenyi
Sarah Namugenyi
ARAndrew Rambaut
Andrew Rambaut
Background Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections (LTRIs) in young children and adults over 65, contributing significantly to global healthcare burdens. With the recent approval of multiple pharmacological interventions for RSV, there is an increased demand for efficient, high-throughput sequencing methods to monitor RSV genetic diversity and any potential impact these interventions may have. Method To address this, we introduce two novel amplicon-based sequencing schemes designed for RSV A and B, optimised for integration with widespread existing ARTIC sequencing workflows. To examine their effectiveness at sequencing RSV samples from across the globe, eight external laboratories used these primers in their sequencing workflows, using both Illumina and Nanopore sequencing technologies. Results We demonstrate that these primer schemes can produce high quality genomes from a diverse range of RSV samples, with eight laboratories in five countries generating complete genomes on both Nanopore and Illumina sequencing platforms. The ability to effectively multiplex these RSV A and B primer schemes, enables streamlined, high-throughput sequencing without prior subtyping. Furthermore, these results provide a snapshot of the circulating diversity of RSV. Phylogenetic analysis of the 882 samples sequenced for this study suggests only minimal geographic clustering of RSV sequences, underscoring the global nature of RSV spread. It also highlights the distinct lineage dynamics seen between RSV A and B. Conclusions This study represents an advancement in RSV genomics, providing robust tools for global sequencing efforts aimed at tracking RSV evolution and assessing the efficacy of new therapeutic interventions both rapidly and at scale.

3 November 2026 in JMIR Research Protocols
Verified
Journal Article
Open access
ASAryan K Sharma
Aryan K Sharma
AAAlexandra Elisabeta Avanu
Alexandra Elisabeta Avanu
JJJuan Felipe Espitia Jaramillo
Juan Felipe Espitia Jaramillo
NKNiraj S Kukreja
Niraj S Kukreja
MSMonika Singh
Monika Singh
Background: A growing body of research has implicated systemic inflammation in the pathogenesis of diabetic nephropathy (DN), with the neutrophil-to-lymphocyte ratio (NLR) emerging as a potential biomarker. However, individual studies and previous evidence syntheses have reported substantial heterogeneity in patient populations, DN definitions, renal function measures, and NLR thresholds, limiting the comparability and interpretation of findings. The extent to which these clinical and methodological differences contribute to variability in the association between NLR and DN remains insufficiently characterized. Objective: This systematic review aims to quantify the association between NLR and DN across measures of disease presence, severity, and prognosis and to investigate potential sources of between-study heterogeneity through prespecified subgroup, sensitivity, and meta-regression analyses. Methods: The protocol was designed in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. A comprehensive literature search of the MEDLINE (Ovid), Embase, the CENTRAL, and Scopus databases was conducted from inception to February 28, 2025. Eligible studies included adults (aged >18 years) with type 2 diabetes mellitus (T2DM) and evaluated the predictive or prognostic value of NLR in relation to DN, using validated measures of DN including albuminuria, estimated glomerular filtration rate (eGFR), glomerular filtration rate (GFR), or serum creatinine. Randomized and nonrandomized interventional studies and observational studies were eligible, with no language restrictions. Two reviewers independently screened studies and extracted data on NLR levels and relevant effect estimates. The methodological quality of observational studies was assessed using the Newcastle-Ottawa Scale. Meta-analyses were performed in RStudio (version 4.5.1) using standardized mean differences or odds ratios, as appropriate, with 95% CIs. Random-effects models were used, and subgroup, sensitivity, and meta-regression analyses were performed to explore potential sources of heterogeneity. Results: The study was initiated on August 31, 2024, and the protocol was first submitted to PROSPERO (CRD42025641025) on February 6, 2025. The literature search identified 1927 records, of which 805 (41.8%) duplicate records were removed. Following title and abstract screening, 123/1,222 (11%) full-text reports were assessed for eligibility, with 45/123 (36.6%) studies included in the qualitative synthesis and 40/45 in the quantitative synthesis. Screening of search results against the inclusion criteria was completed in March 2025. Data extraction was conducted from March 2025 to May 2025, followed by risk-of-bias and quality assessment from May 2025 to July 2025 and data analysis from July 2025 to October 2025. The completed systematic review and meta-analysis was submitted for publication on May 30, 2026. Conclusions: This systematic review sought to synthesize the available evidence on the association between NLR and DN occurrence, severity, and prognosis in T2DM, examining its potential as a biomarker and the sources of variability across studies. If the anticipated associations are supported, NLR may warrant evaluation within risk-stratification models for T2DM.

19 May 2026 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
LDLezia D’SOuza
Lezia D’SOuza
AAAwais Ahmad
Awais Ahmad
ASAryan Sharma
Aryan Sharma
ADAmandeep Dhugga
Amandeep Dhugga
PKPhilip Kaye
Philip Kaye
AZAbed Zeitoun Zaitoun
Abed Zeitoun Zaitoun
Background: Chronic intestinal pseudo-obstruction refers to neuromuscular disorders causing ineffective motility without blockage. One rare cause is segmental additional muscle coat, a sharply defined smooth muscle band between the muscularis mucosae and muscularis propria. Segmental additional muscle coat is seldom reported and has been linked to developmental disorders like Hirschsprung's disease. We report a rare specimen of colonic segmental additional muscle coat with emphasis on quantitative assessment. Specimen: In our specimen, the patient had lifelong severe constipation and multiple surgeries, including subtotal colectomy due to imminent perforation. Macroscopically, the colon showed marked dilation with mucosal thinning and a distal stenotic segment with wall thickening. Methods: We performed histological, immunohistochemical, and novel quantitative analysis to characterize the additional muscle layer's structure and cellular composition—an approach not previously described. Results: Histology revealed a sharply defined smooth muscle layer within the submucosa, distinct from the muscularis propria, and containing fibrosis. The additional layer was identified exclusively in the distal colon, corresponding to the region of pseudo-obstruction. Quantitative desmin immunostaining showed significantly lower smooth muscle content in the segmental additional muscle coat (43.3%) compared to the muscularis propria (95.5%), with the remainder being fibrous tissue. Calretinin highlighted nerve elements, while DOG1 demonstrated interstitial cells of Cajal in the muscularis propria (2.99%) but only minimally in the segmental additional muscle coat (0.75%). Conclusion: This specimen highlights segmental additional muscle coat as a rare structural abnormality causing colonic pseudo-obstruction. The novel use of quantitative immunohistochemistry provides new insight into its cellular and stromal composition, supporting a developmental origin and expanding the pathological understanding of chronic intestinal pseudo-obstruction.

1 September 2026 in Oxford Medical Case Reports
Verified
Journal Article
Open access
JCJaimin P Chauhan
Jaimin P Chauhan
ASAryan K Sharma
Aryan K Sharma
AZAbed Zeitoun Zaitoun
Abed Zeitoun Zaitoun
DLDileep Lobo
Dileep Lobo
We retrospectively reviewed histopathological and immunohistochemical data from patients with mixed exocrine-neuroendocrine intraductal papillary mucinous neoplasms (IPMNs) of the pancreas identified at a single centre between December 2023 and June 2026. Surgical specimens underwent detailed evaluation, including mucin profiling (MUC1, MUC2, MUC5AC) and neuroendocrine markers (synaptophysin, chromogranin A). Ten patients (median age 68.5 years, range: 31–78 years; 6 male) presented mainly with abdominal pain, weight loss, or jaundice. Most lesions were intestinal type IPMNs with focal or interspersed neuroendocrine components. Mucin expression patterns aligned with established subtype profiles, and neuroendocrine differentiation was confirmed immunohistochemically. Only one of the lesions met the World Health Organization (WHO) criteria for mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) due to the non-invasive IPMN component. This case series highlights a distinct subset of mixed non-invasive IPMN-neuroendocrine tumours not currently recognized in WHO classifications. We propose recognition of this entity to improve diagnostic precision and guide management.